Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CRYM Stock Summary
In the News
CRYM Financial details
Company Rating
Sell
Market Cap
7.98M
Income
-15.15M
Revenue
932.84K
Book val./share
-0.02
Cash/share
0
Dividend
-
Dividend %
-
Employees
6
Optionable
No
Shortable
Yes
Earnings
15 May 2024
P/E
-0.68
Forward P/E
-
PEG
0.3
P/S
11.16
P/B
-3.01
P/C
-
P/FCF
-2.35
Quick Ratio
-
Current Ratio
0.11
Debt / Equity
-0.78
LT Debt / Equity
-0.71
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-45.65%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-77.42%
-
-
-
-
SMA20
-
SMA50
-20%
SMA100
-42.86%
Inst Own
-
Inst Trans
-
ROA
-1413%
ROE
-3892%
ROC
16.19%
Gross Margin
50%
Oper. Margin
-1575%
Profit Margin
-1624%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0211-0.1799
52W High
-
52W Low
-
RSI
47.56
Rel Volume
0.22
Avg Volume
125.23K
Volume
27.68K
Perf Week
7.32%
Perf Month
-20.95%
Perf Quarter
-57.62%
Perf Half Y
-54.91%
-
-
-
-
Beta
0.122
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0381
Change
-4.51%
CRYM Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.01 | -0.03 | -0.07 | -0.1 | -0.05 | |
Operating cash flow per share | -0.01 | -0.02 | -0.04 | -0.04 | -0.02 | |
Free cash flow per share | -0.01 | -0.02 | -0.04 | -0.04 | -0.03 | |
Cash per share | 0 | 0.04 | 0 | 0.04 | 0.01 | |
Book value per share | 0.01 | 0.14 | 0.04 | 0.09 | 0.02 | |
Tangible book value per share | 0.01 | 0.06 | 0.04 | 0.05 | 0 | |
Share holders equity per share | 0.01 | 0.14 | 0.04 | 0.09 | 0.02 | |
Interest debt per share | 0 | 0.02 | 0.01 | 0.02 | 0.01 | |
Market cap | 734.32K | 57.48M | 19.87M | 42.53M | 37.18M | |
Enterprise value | 527.01K | 55.55M | 20.01M | 36.93M | 37.17M | |
P/E ratio | -1.72 | -18.94 | -2.89 | -2.83 | -3.57 | |
Price to sales ratio | 0 | 3.15M | 25.43K | 0 | 0 | |
POCF ratio | -1.62 | -32.02 | -5.3 | -7.59 | -7.8 | |
PFCF ratio | -0.81 | -31.35 | -5.3 | -7.3 | -7.2 | |
P/B Ratio | 1.14 | 4.62 | 5.51 | 3.14 | 8.13 | |
PTB ratio | 1.14 | 4.62 | 5.51 | 3.14 | 8.13 | |
EV to sales | 0 | 3.04M | 25.6K | 0 | 0 | |
Enterprise value over EBITDA | -1.56 | -19.35 | -3.06 | -4.65 | -3.66 | |
EV to operating cash flow | -1.16 | -30.94 | -5.34 | -6.59 | -7.8 | |
EV to free cash flow | -0.58 | -30.31 | -5.34 | -6.34 | -7.19 | |
Earnings yield | -0.58 | -0.05 | -0.35 | -0.35 | -0.28 | |
Free cash flow yield | -1.24 | -0.03 | -0.19 | -0.14 | -0.14 | |
Debt to equity | 0 | 0.12 | 0.13 | 0.01 | 0.44 | |
Debt to assets | 0 | 0.1 | 0.06 | 0.01 | 0.25 | |
Net debt to EBITDA | 0.62 | 0.67 | -0.02 | 0.7 | 0 | |
Current ratio | 4.32 | 2.52 | 1.89 | 3.47 | 1.68 | |
Interest coverage | -8.56 | -237.78 | -27.58 | -3.65 | -70.14 | |
Income quality | 1.06 | 0.59 | 0.55 | 0.55 | 0.46 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 166.11K | 8.39K | 0 | 0 | |
Research and developement to revenue | 0 | 26.17K | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.54 | 0 | 0.34 | 0.66 | |
Capex to operating cash flow | 1.01 | 0.02 | 0 | 0.04 | 0.08 | |
Capex to revenue | 0 | -2.07K | 0 | 0 | 0 | |
Capex to depreciation | -623.8 | -0.26 | 0 | -5.15 | -2.55 | |
Stock based compensation to revenue | 0 | 8.26K | 1.84K | 0 | 0 | |
Graham number | 0.03 | 0.32 | 0.24 | 0.43 | 0.16 | |
ROIC | -0.46 | -0.2 | -1.61 | -0.87 | -1.57 | |
Return on tangible assets | -0.61 | -0.41 | -0.88 | -1.45 | -3.87 | |
Graham Net | 0 | 0.01 | -0.03 | 0.02 | -0.01 | |
Working capital | 189.17K | 2.37M | 3.67M | 4.65M | 878.03K | |
Tangible asset value | 646.53K | 5.01M | 3.61M | 8.3M | -596.11K | |
Net current asset value | 189.17K | 1.6M | 3.61M | 4.47M | -1.12M | |
Invested capital | 0 | 0.12 | 0.13 | 0.01 | 0.44 | |
Average receivables | 0 | 0 | 270K | 270K | 0 | |
Average payables | 85.92K | 402.02K | 1.5M | 2.06M | 1.59M | |
Average inventory | 5.23K | 175.23K | 170K | 0 | 0 | |
Days sales outstanding | 0 | 0 | 252.22K | 0 | 0 | |
Days payables outstanding | 0 | 1.39M | 1.1M | 15.73K | 2.9K | |
Days of inventory on hand | 0 | 624.18K | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0.02 | 0.13 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.66 | -0.24 | -1.91 | -1.11 | -2.28 | |
Capex per share | -0.01 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.01 | -0.03 | -0.01 | -0.03 | -0.01 | |
Operating cash flow per share | 0 | 0 | -0.01 | 0 | 0 | |
Free cash flow per share | 0 | -0.01 | -0.01 | -0.01 | 0 | |
Cash per share | 0.02 | 0.01 | 0 | 0 | 0 | |
Book value per share | 0.05 | 0.02 | 0.02 | -0.01 | -0.02 | |
Tangible book value per share | 0.02 | 0 | -0.01 | -0.01 | -0.02 | |
Share holders equity per share | 0.05 | 0.02 | 0.02 | -0.01 | -0.02 | |
Interest debt per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Market cap | 47.49M | 37.51M | 28.56M | 28.71M | 19.23M | |
Enterprise value | 46.36M | 37.49M | 29.9M | 30.92M | 21.88M | |
P/E ratio | -9.87 | -1.67 | -4.15 | -1.13 | -3.31 | |
Price to sales ratio | 0 | 40.21 | 0 | 0 | 0 | |
POCF ratio | -53.66 | -41.06 | -21.34 | -28.74 | -21.99 | |
PFCF ratio | -51.69 | -33.03 | -21.13 | -27.75 | -21.38 | |
P/B Ratio | 4.84 | 8.2 | 9.05 | -10.42 | -5.63 | |
PTB ratio | 4.84 | 8.2 | 9.05 | -10.42 | -5.63 | |
EV to sales | 0 | 40.19 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -37.63 | -6.92 | -21.25 | -24.02 | -16.29 | |
EV to operating cash flow | -52.39 | -41.05 | -22.34 | -30.95 | -25.02 | |
EV to free cash flow | -50.46 | -33.02 | -22.11 | -29.88 | -24.32 | |
Earnings yield | -0.03 | -0.15 | -0.06 | -0.22 | -0.08 | |
Free cash flow yield | -0.02 | -0.03 | -0.05 | -0.04 | -0.05 | |
Debt to equity | 0.2 | 0.44 | 0.63 | -0.92 | -0.78 | |
Debt to assets | 0.15 | 0.25 | 0.3 | 1.86 | 2.48 | |
Net debt to EBITDA | 0.92 | 0 | -0.95 | -1.71 | -1.97 | |
Current ratio | 2.64 | 1.68 | 0.54 | 0.26 | 0.11 | |
Interest coverage | -63.85 | -98.25 | -28.54 | -75.96 | -12.56 | |
Income quality | 0.72 | 0.16 | 0.84 | 0.16 | 0.6 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 5.81 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.02 | 0 | 0 | 0 | |
Intangibles to total assets | 0.4 | 0.66 | 0.77 | 0.1 | 0.11 | |
Capex to operating cash flow | 0.04 | 0.24 | 0.01 | 0.04 | 0.03 | |
Capex to revenue | 0 | -0.24 | 0 | 0 | 0 | |
Capex to depreciation | -1.55 | -2.43 | -0.11 | -0.25 | -0.83 | |
Stock based compensation to revenue | 0 | 0.33 | 0 | 0 | 0 | |
Graham number | 0.08 | 0.12 | 0.05 | 0.1 | 0.05 | |
ROIC | -0.1 | -0.84 | -0.32 | 27.37 | 1.95 | |
Return on tangible assets | -0.15 | -2.08 | -1.13 | -5.18 | -1.52 | |
Graham Net | 0 | -0.01 | -0.01 | -0.02 | -0.02 | |
Working capital | 2.03M | 878.03K | -652.68K | -1.34M | -1.76M | |
Tangible asset value | 4.6M | -596.11K | -1.92M | -2.89M | -3.53M | |
Net current asset value | 31.37K | -1.12M | -2.65M | -3.63M | -4.27M | |
Invested capital | 0.2 | 0.44 | 0.63 | -0.92 | -0.78 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.16M | 1.26M | 1.36M | 1.51M | 1.66M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 5.09K | 248.62 | 1.03K | 992.06 | 5.16K | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.02 | 0.36 | 0.09 | 0.09 | 0.02 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.12 | -1.23 | -0.54 | 2.31 | 0.43 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CRYM Frequently Asked Questions
What is Cryomass Technologies Inc. stock symbol ?
Cryomass Technologies Inc. is a US stock , located in Denver of Co and trading under the symbol CRYM
What is Cryomass Technologies Inc. stock quote today ?
Cryomass Technologies Inc. stock price is $0.0381 today.
Is Cryomass Technologies Inc. stock public?
Yes, Cryomass Technologies Inc. is a publicly traded company.